MARATTO

article · PubMed

Assessment of neurocognitive function in patients with Behçet's disease.

20241 citationOpen accessMinia University

Abstract

Cognitive dysfunction is reported in BD patients distinctly and independently of clinically overt neurologic involvement. Prevalence of cognitive impairment in patients with BD is strikingly high at 37.5%, whereas the control group exhibited no such signs. Psychological assessment should be performed for every BD patient to reveal any cognitive involvement. It is highly recommended to encourage psychological intervention to prevent any further deterioration, especially in patients who are experiencing depression or currently using corticosteroids.

Research topics

  • Ocular Diseases and Behçet’s Syndrome
  • Ophthalmology and Visual Health Research
  • Retinal and Optic Conditions

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.5114/reum.2024.141289

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.